Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once-Daily Tacrolimus Formulations: The BITACORA Study.

Puntos clave

• The research investigates the clinical outcomes and quality of life for older kidney transplant recipients on a once-daily tacrolimus regimen.
• Monitored older de novo kidney transplant recipients for one year post-transplant
• Evaluated incidence of biomarkers like BPAR and graft loss
• Assessed quality of life changes in the patient population
• Low incidence of biopsy-proven acute rejection (BPAR)
• Minimal graft loss observed during the study period
• Patients reported overall improvement in quality of life

Resumen